Kinemed Raises $15 Million

Kinemed Inc., an Emeryville, Calif.-based drug company whose lead compound is designed to help treat ALS, has raised $15 million in convertible note funding. Stanford Financial Group led the deal, while Ledgemont Capital served as placement agent. www.kinemed.com